Your Questions Answered

Does seeing a patient via telepsychiatry complicate the Abnormal Involuntary Movement Scale (AIMS) exam? Find out from Psych Congress cochair Rakesh Jain, MD, MPH. 

Karl Doghramji, MD, Medical Director of the Jefferson Sleep Disorders Center in Philadelphia shares tips for choosing insomnia treatments for older patients with dementia.

Psych Congress Regionals is a series of 1-day educational events designed to offer insightful sessions on relevant mental health topics providing attendees with the latest advances in diagnosis and treatment.

Empowering clinicians to advance their psychopharmacology, psychotherapy, and wellness knowledge.

Elevate challenges attendees to ask those questions keeping them up at night. Encourages them to discover new perspective and gain a mentor and a network to tap into year-round. Inspires them to advance their career path and the future of mental…

Psych Congress Steering Committee member Vladimir Maletic, MD, MS, explores the research on the relationship between diet, caloric restriction, and symptoms of depression.

Is there any rationale for using both deutetrabenazine (Austedo) and valbenazine (Ingrezza) at the same time? Find out from Psych Congress cochair Rakesh Jain, MD, MPH.

Is there benefit in treating a patient with a VMAT2 inhibitor if they have already had severe tardive dyskinesia for several years? Find out here.

Should we treat patients who are on Suboxone or methadone with stimulants? Psych Congress cochair Rakesh Jain, MD, MPH, outlines several points to consider. 

Are medications for tardive dyskinesia effective in mild, moderate, or severe cases? Get the answer from Psych Congress cochair Rakesh Jain, MD, MPH.